Clinical Trials Logo

Neoplasm Metastasis clinical trials

View clinical trials related to Neoplasm Metastasis.

Filter by:

NCT ID: NCT03038841 Recruiting - Metastatic Cancer Clinical Trials

Mobile Health Technology for Palliative Care Patients

Start date: February 1, 2017
Phase: N/A
Study type: Observational [Patient Registry]

To test the potential and acceptance of wireless activity tracking in palliative care patients leaving hospital care. Explorative study, collaboration project of the Clinic of Radiation-Oncology, University Hospital Zurich and the Wearable Computing Laboratory, Swiss Federal Institut of Technology. Patients receive a tracking bracelet and a smart phone in order to gather objective physical activity parameters as step count, sleep duration, heart rate, social activity patterns (e.g. making calls) as well as subjective ratings of pain and distress. Quality of life (QoL) will be captured by paper questionnaire. Correlations between patients' physical activity patterns and the pain and distress level assessed from electronic scales as well as QoL-questionnaire will be performed. Acceptance will be evaluated by quantitative questionnaires and interviews. The proposed study is meant to be preparatory work for an intervention study to test the effect of wireless monitoring of palliative care patients on fostering early interventions for symptom relief and support of QoL.

NCT ID: NCT03028337 Recruiting - Clinical trials for Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System

Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases

Start date: January 18, 2017
Phase: Phase 2
Study type: Interventional

The goal of this clinical research study is to learn whether delivering spine radiosurgery in a single large dose is better than delivering spine radiosurgery over 3 smaller doses. Researchers also want to learn about the effects of a single dose on participant's symptoms, pain, and quality-of-life.

NCT ID: NCT03027544 Recruiting - Brain Metastases Clinical Trials

Tomotherapy for Refractory Brain Metastases

TRBM
Start date: September 1, 2014
Phase: N/A
Study type: Interventional

This clinical trial was designed to investigate the efficiency and toxicity of tomotherapy for refractory brain metastases.

NCT ID: NCT03002532 Recruiting - Brain Metastases Clinical Trials

Hippocampal-sparing Whole Brain Radiotherapy for Brain Metastases From Breast Cancer

Start date: August 2015
Phase: N/A
Study type: Interventional

Based on evidence that radiation-induced damage to the hippocampus plays a considerable role in neurocognitive decline after cranial irradiation, hippocampal-sparing whole brain radiation therapy (HS-WBRT) has been proposed. This study will investigate the neurocognitive function and prognosis between HS-WBRT and conventional WBRT for the treatment of brain metastases from breast cancer.

NCT ID: NCT02992769 Recruiting - Clinical trials for Breast Cancer Female

Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary Ultrasound

Start date: March 2016
Phase: N/A
Study type: Observational

Axillary lymph node status is a vital prognostic factors in breast cancer patients and provides crucial information for making treatment decisions.This projective observational study is planned to identify risk factors for axillary metastases in breast cancer patients with axillary ultrasound and to construct a nomogram to predict the risk of axillary metastases in these patients.

NCT ID: NCT02966574 Recruiting - Clinical trials for Metastatic Breastcancer

Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers

Start date: December 13, 2016
Phase: N/A
Study type: Interventional

Whole-body MRI including diffusion is a booming technique. Numerous studies have demonstrated its interest in metastatic cancers. Breast cancers, especially hormone-sensitive ones, are very osteophilic and bones are the most frequent metastatic site. Apart from morphological criteria (lesion size and RECIST criteria), MRI provides quantitative functional criteria (diffusion and ADC values). According to a recent study, whole body MRI is as good as PET/CT and more effective than bone scintigraphy for the diagnosis of bone metastases for cancers of breast and prostate with a high metastatic risk. Therefore, it seems appropriate to study the performance of whole body MRI in the pre-therapeutic assessment of breast cancer with a high risk for metastasis and the monitoring of metastatic breast cancer.

NCT ID: NCT02936388 Recruiting - Uveal Melanoma Clinical Trials

Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver Metastasis

SirTac
Start date: January 2016
Phase: Phase 2
Study type: Interventional

Characterisation of effect of SIRT and DSM-TACE as local treatment options for liver metastases in patients with advanced uveal melanoma with respect to progression-free survival and exploratory comparison of secondary endpoints regarding application, activity, adverse effects and impact on quality of life in a randomized study design.

NCT ID: NCT02917707 Recruiting - Metastasis Clinical Trials

Integrative Analysis of CRC Liver Metastasis

CRC-LM
Start date: January 2016
Phase: N/A
Study type: Observational

The investigators will perform integrative analysis of CRC liver metastasis

NCT ID: NCT02896335 Recruiting - Clinical trials for Metastatic Malignant Neoplasm to Brain

Palbociclib In Progressive Brain Metastases

Start date: February 14, 2017
Phase: Phase 2
Study type: Interventional

This research study is studying palbociclib as a possible treatment for recurrent brain metastases. - Pfizer, a pharmaceutical company, is supporting this research study by providing the study drug as well as funding for research activities

NCT ID: NCT02887651 Recruiting - Surgery Clinical Trials

Cavity Boost Radiation Therapy vs. Observation in Cerebral Metastases After Complete Surgical Resection

C-O-MET
Start date: November 14, 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a local fractionated radiation therapy achieves a better local tumor control after complete surgical metastases resection at 6 month as compared to observation alone. Further it should be evaluated if cognitive functioning and quality of life is similar in both groups.